Image Credit: Cara Medical
Cara Medical, a privately-held company founded by Prof. Shlomo Ben-Haim, announced that it has received 510(k) clearance for the CARA System, a computed tomography angiography (CTA)-based platform that provides noninvasive, patient-specific three-dimensional (3D) visualization of the cardiac conduction system.
The CARA System, which received FDA Breakthrough Device Designation last year, enables visualization of the location of the cardiac conduction system relative to surrounding cardiac structures during structural heart and pacing procedures.
I believe this will be a game-changer for conduction system pacing since it provides the ability to precisely guide the positioning of leads for Conduction System Pacing.
According to the press release, the CARA System integrates two core components:
- CARA MetisTM Simulator – A preprocedural planning software that utilizes CTA-based anatomical landmarks to identify the cardiac conduction axis and generate a personalized 3D map of the patient’s cardiac conduction system.
- CARA AtlasTM Navigator – An intraprocedural guidance platform that overlays the patient-specific conduction system model generated by the Metis onto live fluoroscopic images to assist physicians during image-guided interventions.